17 hours ago
1
quantic69/iStock via Getty Images
- Novo Nordisk (NVO) has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has given a positive recommendation to update the label for Alhemo (concizumab).
- This update will allow the treatment of severe haemophilia A
English (US) ·